These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 16978262)

  • 1. The future role of intelligent probes in detecting and managing prostate cancer.
    Kommu SS; Andrews RJ; Mah RW
    BJU Int; 2006 Oct; 98(4):717-9. PubMed ID: 16978262
    [No Abstract]   [Full Text] [Related]  

  • 2. Electrical impedance spectroscopy of the human prostate.
    Halter RJ; Hartov A; Heaney JA; Paulsen KD; Schned AR
    IEEE Trans Biomed Eng; 2007 Jul; 54(7):1321-7. PubMed ID: 17605363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MR-guided interventions of the prostate gland.
    Zangos S; Eichler K; Thalhammer A; Schoepf JU; Costello P; Herzog C; Mack MG; Vogl TJ
    Minim Invasive Ther Allied Technol; 2007; 16(4):222-9. PubMed ID: 17763096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnosis and treatment of prostate cancer--it's diversity and future prospects].
    Ogawa O
    Hinyokika Kiyo; 2001 Feb; 47(2):131-8. PubMed ID: 11280887
    [No Abstract]   [Full Text] [Related]  

  • 5. Dystroglycan expression is reduced during prostate tumorigenesis and is regulated by androgens in prostate cancer cells.
    Sgambato A; De Paola B; Migaldi M; Di Salvatore M; Rettino A; Rossi G; Faraglia B; Boninsegna A; Maiorana A; Cittadini A
    J Cell Physiol; 2007 Nov; 213(2):528-39. PubMed ID: 17516554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cryotherapy for the prostate: an in vitro and clinical study of two new developments; advanced cryoneedles and a temperature monitoring system.
    Gowardhan B; Greene D
    BJU Int; 2007 Aug; 100(2):295-302. PubMed ID: 17511766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-voltage electronic diagnostic devices.
    Med Lett Drugs Ther; 2008 Dec; 50(1300):95-6. PubMed ID: 19037188
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cancer of the prostate: recent findings and the immediate future].
    Ravaud A; Bay JO
    Bull Cancer; 2007 Jul; 94(7 Suppl):F3-4. PubMed ID: 17845987
    [No Abstract]   [Full Text] [Related]  

  • 9. The application of nanotechnology for the treatment of metastatic prostate cancer.
    Fitzpatrick JM
    BJU Int; 2009 Sep; 104(6):i. PubMed ID: 19706031
    [No Abstract]   [Full Text] [Related]  

  • 10. Counseling the patient with prostate cancer.
    Bissada NK
    J S C Med Assoc; 2000 Feb; 96(2):90-1. PubMed ID: 10710909
    [No Abstract]   [Full Text] [Related]  

  • 11. Prostate cancer: screening, diagnosis and management in 2007.
    Grubb RL; Kibel AS
    Mo Med; 2007; 104(5):408-13; quiz 413-4. PubMed ID: 18018527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimizing the management of prostate diseases: prostate cancer. Introduction.
    Fitzpatrick JM
    BJU Int; 2008 Mar; 101 Suppl 2():1. PubMed ID: 18307684
    [No Abstract]   [Full Text] [Related]  

  • 13. Considerations on prostate cancer: diagnosis and treatment decisions.
    Herrmann TR; Merseburger AS; Burchardt M
    World J Urol; 2009 Oct; 27(5):579-80. PubMed ID: 19756633
    [No Abstract]   [Full Text] [Related]  

  • 14. The role of MRI and MRSI in diagnosis, treatment selection, and post-treatment follow-up for prostate cancer.
    Fuchsjäger M; Akin O; Shukla-Dave A; Pucar D; Hricak H
    Clin Adv Hematol Oncol; 2009 Mar; 7(3):193-202. PubMed ID: 19398944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expanding role of epigenetics in the development, diagnosis and treatment of prostate cancer and benign prostatic hyperplasia.
    Dobosy JR; Roberts JL; Fu VX; Jarrard DF
    J Urol; 2007 Mar; 177(3):822-31. PubMed ID: 17296351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate cancer screening; is this a teachable moment?
    Brawley OW
    J Natl Cancer Inst; 2009 Oct; 101(19):1295-7. PubMed ID: 19720970
    [No Abstract]   [Full Text] [Related]  

  • 17. Prostate-specific antigen kinetics and the diagnosis and management of prostate cancer.
    Goldstraw MA; Fitzpatrick JM; Kirby RS
    BJU Int; 2006 Dec; 98(6):1141-2. PubMed ID: 17125469
    [No Abstract]   [Full Text] [Related]  

  • 18. Information from your family doctor. Early prostate cancer: what you should know.
    American Academy of Family Physicians
    Am Fam Physician; 2005 May; 71(10):1929-30. PubMed ID: 15926408
    [No Abstract]   [Full Text] [Related]  

  • 19. Artificial neural networks: has the time come for their use in prostate cancer patients?
    Stephan C; Cammann H; Jung K
    Nat Clin Pract Urol; 2005 Jun; 2(6):262-3. PubMed ID: 16474814
    [No Abstract]   [Full Text] [Related]  

  • 20. Citrate concentrations in human seminal fluid and expressed prostatic fluid determined via 1H nuclear magnetic resonance spectroscopy outperform prostate specific antigen in prostate cancer detection.
    Kline EE; Treat EG; Averna TA; Davis MS; Smith AY; Sillerud LO
    J Urol; 2006 Nov; 176(5):2274-9. PubMed ID: 17070311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.